No anti-doping violations were detected in floorball in 2020, the International Floorball Federation (IFF) has reported.
There were 34 drug tests carried out on floorball players in 2020 - down sharply from 93 in 2019, which the IFF has blamed on the coronavirus pandemic.
Of those tests, 16 were conducted during competitions and 18 were out-of-competition samples.
No anti-doping rule violations were detected.
The IFF added that three of the collected urine samples were tested for erythropoiesis-stimulating agents and three for growth hormone-releasing factors, ensuring that the five per cent target laid out in the World Anti-Doping Agency Technical Document for Sport Specific Analysis was met for both substance groups.
"The amount of doping controls was significantly lower than originally planned due to the Covid-19 pandemic that effected many of the planned events both on the national and international level," said IFF communications and anti-doping Manager Merita Bruun.
"There were still some tests conducted during the year, and the Anti-Doping Organisations are following the COVID-19 testing guidelines published by the World Anti-Doping Agency."
In 2019, there were 54 IFF-initiated anti-doping tests and 39 out-of-competition tests.
The 2018 total was 91 and a year before that 98.